Drug discovery Archives

Latest Posts

metrion drug discovery cardiac risk eurostars

News and Trends 22 Mar 2016

Eurostars grants Metrion €2.2M for Novel Drug Discovery Tests

Metrion Biosciences (UK) is receiving €2.2M in funding for its project to develop phenotypic cardiac safety assays, that could make drug discovery cheaper and faster. Metrion is a Contract Research Organization out of the Babraham Institute in Cambridge (one of the 10 hottest bioincubators in Europe). It provides screening services for drugs still in the discovery […]

March 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Dec 2015

“Structural Biology is changing the way we design drugs”

Structural biology, the study of the structure of biological macromolecules, is becoming a real asset in the drug development process. The PSDI meeting is THE not-to-be-missed event for the experts in this field. Labiotech.eu gives you a glimpse of the last trends discussed during this conference thanks to our exclusive interview with Dr Peter Reinemer, […]

December 10, 2015 - 5 minutesmins - By Joachim Eeckhout

News and Trends 14 Mar 2015

Promising Collaboration Between Evotec and Second Genome

Evotec AG and Second Genome decided to collaborate in small molecule-based discovery and development activities for the treatment of microbiome-mediated diseases. The collaboration comprises the identification and optimisation of novel compounds as well as licence agreements for already existing assets developed by Evotec. Second Genome’s unique approach to identify and modulate microbiome-mediated pathways will be […]

March 14, 2015 - 2 minutesmins - By Julie Lellouche

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us